Institution
Royal South Hants Hospital
Healthcare•Southampton, United Kingdom•
About: Royal South Hants Hospital is a healthcare organization based out in Southampton, United Kingdom. It is known for research contribution in the topics: Population & Poison control. The organization has 779 authors who have published 853 publications receiving 36518 citations. The organization is also known as: The RSH.
Papers published on a yearly basis
Papers
More filters
••
TL;DR: Irinotecan combined with fluorouracil and calcium folinate was well-tolerated and increased response rate, time to progression, and survival, with a later deterioration in quality of life.
3,176 citations
••
TL;DR: The recommendations described in this report were proposed based on clinical experience and dosimetric concepts of different institutions (IGR, Leuven, Vienna) and were stepwise validated against the background of different clinical experience.
1,325 citations
••
TL;DR: The available evidence suggests that schizophrenia is associated with a large increase mortality from suicide and a moderate increased mortality from natural causes.
Abstract: BACKGROUND This paper presents a structured review of the published information on the mortality of schizophrenia.
METHOD A meta-analysis of the literature.
RESULTS Schizophrenia has a significantly increased mortality from natural and unnatural causes. Twenty-eight percent of the excess mortality is attributable to suicide and 12% to accidents. The rest of the excess mortality is from the same broad range of conditions which cause deaths in the general population. Further interpretation is hampered by confounding variables, wide confidence intervals and reservations about generalising from individual cohorts.
CONCLUSIONS The available evidence suggests that schizophrenia is associated with a large increased mortality from suicide and a moderate increased mortality from natural causes. A number of possible interventions have been identified, but we do not yet have reliable means of detecting any changes in mortality which might result.
880 citations
••
TL;DR: Once-daily suppressive therapy with valacyclovir significantly reduces the risk of transmission of genital herpes among heterosexual, HSV-2-discordant couples.
Abstract: Background Nucleoside analogues against herpes simplex virus (HSV) have been shown to suppress shedding of HSV type 2 (HSV-2) on genital mucosal surfaces and may prevent sexual transmission of HSV. Methods We followed 1484 immunocompetent, heterosexual, monogamous couples: one with clinically symptomatic genital HSV-2 and one susceptible to HSV-2. The partners with HSV-2 infection were randomly assigned to receive either 500 mg of valacyclovir once daily or placebo for eight months. The susceptible partner was evaluated monthly for clinical signs and symptoms of genital herpes. Source partners were followed for recurrences of genital herpes; 89 were enrolled in a substudy of HSV-2 mucosal shedding. Both partners were counseled on safer sex and were offered condoms at each visit. The predefined primary end point was the reduction in transmission of symptomatic genital herpes. Results Clinically symptomatic HSV-2 infection developed in 4 of 743 susceptible partners who were given valacyclovir, as compared w...
635 citations
••
TL;DR: It is demonstrated that genetic linkage of two DNA polymorphisms on the long arm of human chromosome 5 to schizophrenia in seven British and Icelandic families with multiple affected members provides the first strong evidence for the involvement of a single gene in the causation of schizophrenia.
Abstract: Schizophrenia is a common disorder with a life time prevalence of approximately 1 per cent. The illness often develops in young adults, who were previously normal, and is characterized by a constellation of symptoms including hallucinations and delusions (psychotic symptoms) and symptoms such as severely inappropriate emotional responses, a disorder of thinking and concentration, erratic behaviour as well as social and occupational deterioration. A considerable proportion of the variance in the liability to develop schizophrenia may be genetic, but segregation analysis, to establish a mode of transmission, has not produced a consistent result. One of these studies was carried out in Iceland and made use of the large family size and extensive geneaological information present in that country. Here we demonstrate genetic linkage of two DNA polymorphisms on the long arm of human chromosome 5 to schizophrenia in seven British and Icelandic families with multiple affected members. The results indicate the existence of a gene locus with a dominant schizophrenia-susceptibility allele. Inheritance of the allele in the families studied suggests that it may also predispose to psychiatric conditions such as schizophrenia spectrum disorders and a variety of other disorders. This report provides the first strong evidence for the involvement of a single gene in the causation of schizophrenia.
585 citations
Authors
Showing all 779 results
Name | H-index | Papers | Citations |
---|---|---|---|
Andreas K. Engel | 82 | 413 | 40586 |
Michael J. Campbell | 80 | 412 | 28875 |
David S. Baldwin | 76 | 450 | 17521 |
Graham S. Ogg | 69 | 308 | 26757 |
Jerry S. Trier | 64 | 147 | 11552 |
Robert Sutton | 63 | 324 | 13499 |
Stefan Debener | 55 | 170 | 13600 |
Stephen Birch | 54 | 402 | 9690 |
Timothy M Illidge | 53 | 246 | 11995 |
Christian H. Ottensmeier | 53 | 234 | 21718 |
John G. Edwards | 51 | 162 | 10847 |
Robert Peveler | 49 | 110 | 10265 |
David Kerr | 49 | 276 | 8866 |
Eugene Healy | 45 | 132 | 7592 |
David Kingdon | 43 | 248 | 7679 |